Published

Psychedelic therapy: Fresh promise for mental health

Psychedelic-assisted psychotherapy is seeing a resurgence as a treatment approach for mental health disorders. It melds pharmacology and psychotherapy, using substances such as lysergic acid diethylamide (LSD) and psilocybin, under medical supervision, to treat conditions such as post-traumatic stress disorder (PTSD) and extreme depression.

Open source BibTeX RIS

Bibliographic context

Journal: Mental Health Weekly
Date: 2020-01-23
Source: OpenAlex
DOI: 10.1002/mhw.32207
PubMed: Unavailable

Authors

Heidi Bush

Watch author

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Psychedelic therapy: Fresh promise for mental health2020-01-23

Related papers

Plant Medicine Healing! Discovering the Roots of Psychedelic-Assisted Therapy in Mental HealthAdvances in Research · 2023-01-29 Psychedelics and mental health: reimagining care through science, insight, and compassionFrontiers in Pharmacology · 2025-09-02 PSYCHEDELIC PHARMACOLOGY IN PSYCHIATRY: THE MECHANISMS AND THERAPEUTIC POTENTIAL OF PSILOCYBIN, MDMA, AND LSD IN MENTAL HEALTH DISORDERSJournal of medical & health sciences review. · 2025-03-10 Psychedelics for Psychiatric Disorders: More Research NeededPsychiatric News · 2020-04-12 The need for publicly funded research on therapeutic use of psychedelic drugsWorld Psychiatry · 2021-05-17 Psychedelics, entactogens and psychoplastogens for depression and related disorders.British journal of pharmacology · 2026-06-30 Strategic Neurodelivery of Psychedelic Compounds: Bridging MolecularPharmacology with Therapeutic Innovation in CNS DisordersCNS & Neurological Disorders - Drug Targets · 2026-03-10